SCHEMBL21049574

SCHEMBL21049574

CCCCC[n+]1ccn(C)c1C(=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
HSP90AA1 P07900 3/20 0.36
RGS12 O14924 2/20 0.36
MAPK1 P28482 2/20 0.36
APAF1 O14727 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.33
HTT P42858 3/20 0.33
GPR84 Q9NQS5 2/20 0.33
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 2/20 0.33
LMNA P02545 2/20 0.33
RAB9A P51151 2/20 0.33
USP2 O75604 1/20 0.33
THRB P10828 1/20 0.33
RAD52 P43351 1/20 0.33
MCL1 Q07820 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22189070 0.98 CA1 (0.48) CA1CA2MEN1KMT2AHSP90AA1
SCHEMBL21049538 0.98 CA1 (0.48) CA1CA2MEN1KMT2AHSP90AA1
SCHEMBL21049628 0.98 CA1 (0.48) CA1CA2MEN1KMT2AHSP90AA1
SCHEMBL21049627 0.98 CA1 (0.48) CA1CA2MEN1KMT2AHSP90AA1
SCHEMBL21049640 0.98 CA1 (0.48) CA1CA2MEN1KMT2AHSP90AA1
SCHEMBL21049590 0.98 CA1 (0.48) CA1CA2MEN1KMT2AHSP90AA1
SCHEMBL1330456 0.95 CA1 (0.40) CA1CA2MEN1KMT2AHSP90AA1
SCHEMBL21049625 0.89 CA1 (0.33) CA1CA2
SCHEMBL28727295 0.88 CA1 (0.40) CA1CA2MEN1KMT2AHSP90AA1
SCHEMBL22958093 0.84 CA1 (0.49) CA1CA2MEN1KMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563050-B Amide salt compound, catalyst for polyurethane production and method for producing polyurethane resin 广荣化学株式会社 2023-06-02 CN disclosed
EP-3604287-B1 PRODUCTION METHOD FOR AMIDATE COMPOUND KOEI CHEMICAL CO (JP) 2022-08-03 EP disclosed
EP-3495353-B1 AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN KOEI CHEMICAL CO (JP) 2021-11-17 EP disclosed
US-10913724-B2 Production method for amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2021-02-09 US disclosed
US-10689478-B2 Amidate compound, catalyst for polyurethane production, and method for producing polyurethane resin KOEI CHEMICAL COMPANY, LIMITED (JP) 2020-06-23 US disclosed
EP-3604287-A1 PRODUCTION METHOD FOR AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2020-02-05 EP disclosed
US-20190177464-A1 AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN KOEI CHEMICAL COMPANY, LIMITED (JP) 2019-06-13 US disclosed
EP-3495353-A1 AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN Koei Chemical Company, Limited (JP) 2019-06-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10913724-B2 Production method for amidate compound NAAA, PAM, CCKBR CA1 362/4885CA2 2198/4885MEN1 374/4885
US-10689478-B2 Amidate compound, catalyst for polyurethane production, and method for producing polyurethane resin ARG1, NIT2, RER1 CA1 1981/4885CA2 3025/4885MEN1 3059/4885
US-20190177464-A1 AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN ARG1, NIT2, RER1 CA1 1981/4885CA2 3025/4885MEN1 3059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.